nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosuvastatin—CYP2C9—brain cancer	0.587	1	CbGaD
Rosuvastatin—ABCC1—Etoposide—brain cancer	0.0649	0.233	CbGbCtD
Rosuvastatin—ABCG2—Carboplatin—brain cancer	0.0517	0.186	CbGbCtD
Rosuvastatin—CYP3A4—Temozolomide—brain cancer	0.0457	0.164	CbGbCtD
Rosuvastatin—ABCG2—Etoposide—brain cancer	0.0434	0.156	CbGbCtD
Rosuvastatin—CYP3A4—Lomustine—brain cancer	0.0388	0.14	CbGbCtD
Rosuvastatin—CYP3A5—Etoposide—brain cancer	0.0241	0.0866	CbGbCtD
Rosuvastatin—CYP3A4—Etoposide—brain cancer	0.00939	0.0338	CbGbCtD
Rosuvastatin—Pitavastatin—CYP2C9—brain cancer	0.00254	0.519	CrCbGaD
Rosuvastatin—Fluvastatin—CYP2C9—brain cancer	0.00235	0.481	CrCbGaD
Rosuvastatin—SLCO2B1—ganglion—brain cancer	0.00166	0.0557	CbGeAlD
Rosuvastatin—SLC7A11—Basigin interactions—BSG—brain cancer	0.00163	0.0638	CbGpPWpGaD
Rosuvastatin—Nephropathy—Etoposide—brain cancer	0.0016	0.0215	CcSEcCtD
Rosuvastatin—Nightmare—Procarbazine—brain cancer	0.00152	0.0205	CcSEcCtD
Rosuvastatin—Gynaecomastia—Procarbazine—brain cancer	0.00141	0.019	CcSEcCtD
Rosuvastatin—Myopathy—Temozolomide—brain cancer	0.00135	0.0183	CcSEcCtD
Rosuvastatin—Hepatic enzyme increased—Hydroxyurea—brain cancer	0.00129	0.0173	CcSEcCtD
Rosuvastatin—SLC7A11—telencephalon—brain cancer	0.00122	0.0408	CbGeAlD
Rosuvastatin—Memory impairment—Temozolomide—brain cancer	0.00121	0.0163	CcSEcCtD
Rosuvastatin—Accidental injury—Carmustine—brain cancer	0.00111	0.015	CcSEcCtD
Rosuvastatin—Drug interaction—Carmustine—brain cancer	0.00106	0.0143	CcSEcCtD
Rosuvastatin—SLCO1B3—pituitary gland—brain cancer	0.00102	0.0342	CbGeAlD
Rosuvastatin—Hepatic enzyme increased—Temozolomide—brain cancer	0.001	0.0135	CcSEcCtD
Rosuvastatin—Infection—Carboplatin—brain cancer	0.001	0.0135	CcSEcCtD
Rosuvastatin—Hepatic failure—Hydroxyurea—brain cancer	0.000982	0.0132	CcSEcCtD
Rosuvastatin—Pancreatitis—Procarbazine—brain cancer	0.000967	0.013	CcSEcCtD
Rosuvastatin—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000959	0.0375	CbGpPWpGaD
Rosuvastatin—Renal failure acute—Hydroxyurea—brain cancer	0.000956	0.0129	CcSEcCtD
Rosuvastatin—Gynaecomastia—Carmustine—brain cancer	0.00088	0.0119	CcSEcCtD
Rosuvastatin—Infection—Lomustine—brain cancer	0.000877	0.0118	CcSEcCtD
Rosuvastatin—SLC7A11—midbrain—brain cancer	0.000875	0.0293	CbGeAlD
Rosuvastatin—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000872	0.0341	CbGpPWpGaD
Rosuvastatin—Thrombocytopenia—Lomustine—brain cancer	0.000865	0.0117	CcSEcCtD
Rosuvastatin—Pain—Carboplatin—brain cancer	0.000863	0.0116	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Procarbazine—brain cancer	0.000862	0.0116	CcSEcCtD
Rosuvastatin—Jaundice—Procarbazine—brain cancer	0.000857	0.0116	CcSEcCtD
Rosuvastatin—SLC7A11—spinal cord—brain cancer	0.000853	0.0286	CbGeAlD
Rosuvastatin—Haematuria—Procarbazine—brain cancer	0.000838	0.0113	CcSEcCtD
Rosuvastatin—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000823	0.0322	CbGpPWpGaD
Rosuvastatin—Diabetes mellitus—Carmustine—brain cancer	0.000821	0.0111	CcSEcCtD
Rosuvastatin—Breast disorder—Hydroxyurea—brain cancer	0.000798	0.0108	CcSEcCtD
Rosuvastatin—SLCO1B3—endocrine gland—brain cancer	0.000791	0.0265	CbGeAlD
Rosuvastatin—Gastroenteritis—Temozolomide—brain cancer	0.000778	0.0105	CcSEcCtD
Rosuvastatin—Injury—Carmustine—brain cancer	0.000776	0.0105	CcSEcCtD
Rosuvastatin—HMGCR—SREBF and miR33 in cholesterol and lipid homeostasis—SIRT1—brain cancer	0.000775	0.0303	CbGpPWpGaD
Rosuvastatin—SLC7A11—endocrine gland—brain cancer	0.000768	0.0258	CbGeAlD
Rosuvastatin—Hepatic failure—Temozolomide—brain cancer	0.000767	0.0103	CcSEcCtD
Rosuvastatin—Amnesia—Carmustine—brain cancer	0.00076	0.0102	CcSEcCtD
Rosuvastatin—SLC7A11—head—brain cancer	0.000758	0.0254	CbGeAlD
Rosuvastatin—HMGCR—telencephalon—brain cancer	0.000757	0.0254	CbGeAlD
Rosuvastatin—Pancreatitis—Hydroxyurea—brain cancer	0.000748	0.0101	CcSEcCtD
Rosuvastatin—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.000743	0.029	CbGpPWpGaD
Rosuvastatin—Amnesia—Temozolomide—brain cancer	0.000734	0.0099	CcSEcCtD
Rosuvastatin—ABCC4—Ectoderm Differentiation—TSC22D1—brain cancer	0.000733	0.0286	CbGpPWpGaD
Rosuvastatin—Arrhythmia—Procarbazine—brain cancer	0.000705	0.00951	CcSEcCtD
Rosuvastatin—SLC7A11—central nervous system—brain cancer	0.000692	0.0232	CbGeAlD
Rosuvastatin—ABCB11—endocrine gland—brain cancer	0.000682	0.0229	CbGeAlD
Rosuvastatin—HMGCR—AMPK Signaling—STRADA—brain cancer	0.000681	0.0266	CbGpPWpGaD
Rosuvastatin—SLC7A11—cerebellum—brain cancer	0.000677	0.0227	CbGeAlD
Rosuvastatin—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000667	0.00899	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Hydroxyurea—brain cancer	0.000643	0.00868	CcSEcCtD
Rosuvastatin—SLCO2B1—telencephalon—brain cancer	0.000641	0.0215	CbGeAlD
Rosuvastatin—HMGCR—gonad—brain cancer	0.000632	0.0212	CbGeAlD
Rosuvastatin—Muscular weakness—Carmustine—brain cancer	0.000629	0.00849	CcSEcCtD
Rosuvastatin—Breast disorder—Temozolomide—brain cancer	0.000623	0.0084	CcSEcCtD
Rosuvastatin—HMGCR—pituitary gland—brain cancer	0.000616	0.0207	CbGeAlD
Rosuvastatin—Muscular weakness—Temozolomide—brain cancer	0.000608	0.0082	CcSEcCtD
Rosuvastatin—Cough—Procarbazine—brain cancer	0.000599	0.00808	CcSEcCtD
Rosuvastatin—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.000596	0.0233	CbGpPWpGaD
Rosuvastatin—HMGCR—medulla oblongata—brain cancer	0.000595	0.0199	CbGeAlD
Rosuvastatin—SLCO1A2—telencephalon—brain cancer	0.00059	0.0198	CbGeAlD
Rosuvastatin—Myalgia—Procarbazine—brain cancer	0.000585	0.00789	CcSEcCtD
Rosuvastatin—Arthralgia—Procarbazine—brain cancer	0.000585	0.00789	CcSEcCtD
Rosuvastatin—Bronchitis—Temozolomide—brain cancer	0.000573	0.00773	CcSEcCtD
Rosuvastatin—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.000573	0.0224	CbGpPWpGaD
Rosuvastatin—Confusional state—Procarbazine—brain cancer	0.000565	0.00762	CcSEcCtD
Rosuvastatin—Infection—Procarbazine—brain cancer	0.000557	0.00751	CcSEcCtD
Rosuvastatin—SLC7A11—brain—brain cancer	0.00055	0.0184	CbGeAlD
Rosuvastatin—Thrombocytopenia—Procarbazine—brain cancer	0.000549	0.0074	CcSEcCtD
Rosuvastatin—Depression—Carmustine—brain cancer	0.000548	0.0074	CcSEcCtD
Rosuvastatin—HMGCR—midbrain—brain cancer	0.000544	0.0182	CbGeAlD
Rosuvastatin—SLC7A11—Cell surface interactions at the vascular wall—BSG—brain cancer	0.000543	0.0212	CbGpPWpGaD
Rosuvastatin—Neuropathy peripheral—Carmustine—brain cancer	0.000539	0.00727	CcSEcCtD
Rosuvastatin—SLCO2B1—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000535	0.0209	CbGpPWpGaD
Rosuvastatin—Urinary tract infection—Carmustine—brain cancer	0.000535	0.00721	CcSEcCtD
Rosuvastatin—HMGCR—spinal cord—brain cancer	0.00053	0.0178	CbGeAlD
Rosuvastatin—Depression—Temozolomide—brain cancer	0.00053	0.00715	CcSEcCtD
Rosuvastatin—Nausea—Lomustine—brain cancer	0.000525	0.00707	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Temozolomide—brain cancer	0.000521	0.00703	CcSEcCtD
Rosuvastatin—Urinary tract infection—Temozolomide—brain cancer	0.000517	0.00697	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000511	0.00689	CcSEcCtD
Rosuvastatin—Insomnia—Procarbazine—brain cancer	0.000507	0.00684	CcSEcCtD
Rosuvastatin—SLCO2B1—medulla oblongata—brain cancer	0.000504	0.0169	CbGeAlD
Rosuvastatin—Paraesthesia—Procarbazine—brain cancer	0.000503	0.00679	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Temozolomide—brain cancer	0.000503	0.00678	CcSEcCtD
Rosuvastatin—Sinusitis—Temozolomide—brain cancer	0.000499	0.00672	CcSEcCtD
Rosuvastatin—ABCC1—telencephalon—brain cancer	0.000484	0.0162	CbGeAlD
Rosuvastatin—Constipation—Procarbazine—brain cancer	0.000479	0.00647	CcSEcCtD
Rosuvastatin—Pain—Procarbazine—brain cancer	0.000479	0.00647	CcSEcCtD
Rosuvastatin—HMGCR—endocrine gland—brain cancer	0.000477	0.016	CbGeAlD
Rosuvastatin—Hepatitis—Temozolomide—brain cancer	0.000477	0.00643	CcSEcCtD
Rosuvastatin—Pharyngitis—Temozolomide—brain cancer	0.000474	0.00639	CcSEcCtD
Rosuvastatin—HMGCR—head—brain cancer	0.000471	0.0158	CbGeAlD
Rosuvastatin—SLCO1A2—medulla oblongata—brain cancer	0.000464	0.0155	CbGeAlD
Rosuvastatin—Feeling abnormal—Procarbazine—brain cancer	0.000462	0.00623	CcSEcCtD
Rosuvastatin—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000461	0.018	CbGpPWpGaD
Rosuvastatin—Gastrointestinal pain—Procarbazine—brain cancer	0.000458	0.00618	CcSEcCtD
Rosuvastatin—SLCO1B1—endocrine gland—brain cancer	0.000457	0.0153	CbGeAlD
Rosuvastatin—ABCC1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000454	0.0177	CbGpPWpGaD
Rosuvastatin—SLCO2B1—spinal cord—brain cancer	0.000449	0.0151	CbGeAlD
Rosuvastatin—Urticaria—Procarbazine—brain cancer	0.000445	0.00601	CcSEcCtD
Rosuvastatin—Abdominal pain—Procarbazine—brain cancer	0.000443	0.00598	CcSEcCtD
Rosuvastatin—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000443	0.0173	CbGpPWpGaD
Rosuvastatin—Arrhythmia—Carmustine—brain cancer	0.000441	0.00595	CcSEcCtD
Rosuvastatin—Mental disorder—Carmustine—brain cancer	0.000433	0.00583	CcSEcCtD
Rosuvastatin—Infection—Hydroxyurea—brain cancer	0.000431	0.00581	CcSEcCtD
Rosuvastatin—HMGCR—central nervous system—brain cancer	0.00043	0.0144	CbGeAlD
Rosuvastatin—Nervous system disorder—Hydroxyurea—brain cancer	0.000426	0.00574	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Hydroxyurea—brain cancer	0.000425	0.00573	CcSEcCtD
Rosuvastatin—SLCO1A2—midbrain—brain cancer	0.000424	0.0142	CbGeAlD
Rosuvastatin—HMGCR—cerebellum—brain cancer	0.000421	0.0141	CbGeAlD
Rosuvastatin—Mental disorder—Temozolomide—brain cancer	0.000418	0.00564	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Etoposide—brain cancer	0.000417	0.00562	CcSEcCtD
Rosuvastatin—Jaundice—Etoposide—brain cancer	0.000415	0.00559	CcSEcCtD
Rosuvastatin—SLCO1A2—spinal cord—brain cancer	0.000414	0.0139	CbGeAlD
Rosuvastatin—Hypersensitivity—Procarbazine—brain cancer	0.000413	0.00557	CcSEcCtD
Rosuvastatin—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000409	0.016	CbGpPWpGaD
Rosuvastatin—SLCO2B1—endocrine gland—brain cancer	0.000405	0.0136	CbGeAlD
Rosuvastatin—Asthenia—Procarbazine—brain cancer	0.000402	0.00542	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Etoposide—brain cancer	0.000402	0.00542	CcSEcCtD
Rosuvastatin—ABCG2—telencephalon—brain cancer	0.000401	0.0134	CbGeAlD
Rosuvastatin—SLCO2B1—head—brain cancer	0.000399	0.0134	CbGeAlD
Rosuvastatin—Pruritus—Procarbazine—brain cancer	0.000397	0.00535	CcSEcCtD
Rosuvastatin—ABCC1—pituitary gland—brain cancer	0.000394	0.0132	CbGeAlD
Rosuvastatin—ABCB11—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000393	0.0154	CbGpPWpGaD
Rosuvastatin—Diarrhoea—Procarbazine—brain cancer	0.000384	0.00517	CcSEcCtD
Rosuvastatin—Dyspepsia—Hydroxyurea—brain cancer	0.000382	0.00515	CcSEcCtD
Rosuvastatin—Angioedema—Temozolomide—brain cancer	0.00038	0.00512	CcSEcCtD
Rosuvastatin—SLCO1A2—endocrine gland—brain cancer	0.000372	0.0125	CbGeAlD
Rosuvastatin—Constipation—Hydroxyurea—brain cancer	0.000371	0.005	CcSEcCtD
Rosuvastatin—Pain—Hydroxyurea—brain cancer	0.000371	0.005	CcSEcCtD
Rosuvastatin—Dizziness—Procarbazine—brain cancer	0.000371	0.005	CcSEcCtD
Rosuvastatin—SLCO1A2—head—brain cancer	0.000368	0.0123	CbGeAlD
Rosuvastatin—Myalgia—Carmustine—brain cancer	0.000366	0.00493	CcSEcCtD
Rosuvastatin—SLCO2B1—central nervous system—brain cancer	0.000365	0.0122	CbGeAlD
Rosuvastatin—Cough—Temozolomide—brain cancer	0.000362	0.00489	CcSEcCtD
Rosuvastatin—ABCC4—endocrine gland—brain cancer	0.000358	0.012	CbGeAlD
Rosuvastatin—Feeling abnormal—Hydroxyurea—brain cancer	0.000358	0.00482	CcSEcCtD
Rosuvastatin—SLCO2B1—cerebellum—brain cancer	0.000356	0.0119	CbGeAlD
Rosuvastatin—ABCC4—head—brain cancer	0.000354	0.0119	CbGeAlD
Rosuvastatin—Confusional state—Carmustine—brain cancer	0.000354	0.00477	CcSEcCtD
Rosuvastatin—Arthralgia—Temozolomide—brain cancer	0.000354	0.00477	CcSEcCtD
Rosuvastatin—Myalgia—Temozolomide—brain cancer	0.000354	0.00477	CcSEcCtD
Rosuvastatin—Rash—Procarbazine—brain cancer	0.000354	0.00477	CcSEcCtD
Rosuvastatin—Dermatitis—Procarbazine—brain cancer	0.000353	0.00476	CcSEcCtD
Rosuvastatin—Headache—Procarbazine—brain cancer	0.000351	0.00474	CcSEcCtD
Rosuvastatin—Infection—Carmustine—brain cancer	0.000348	0.0047	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Carmustine—brain cancer	0.000343	0.00463	CcSEcCtD
Rosuvastatin—Confusional state—Temozolomide—brain cancer	0.000342	0.00461	CcSEcCtD
Rosuvastatin—HMGCR—brain—brain cancer	0.000342	0.0115	CbGeAlD
Rosuvastatin—Infection—Temozolomide—brain cancer	0.000337	0.00454	CcSEcCtD
Rosuvastatin—SLCO1A2—central nervous system—brain cancer	0.000335	0.0112	CbGeAlD
Rosuvastatin—ABCC1—Irinotecan Pathway—APC—brain cancer	0.000333	0.013	CbGpPWpGaD
Rosuvastatin—Nausea—Procarbazine—brain cancer	0.000333	0.00449	CcSEcCtD
Rosuvastatin—Nervous system disorder—Temozolomide—brain cancer	0.000332	0.00448	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Temozolomide—brain cancer	0.000332	0.00448	CcSEcCtD
Rosuvastatin—SLCO1A2—cerebellum—brain cancer	0.000328	0.011	CbGeAlD
Rosuvastatin—ABCG2—pituitary gland—brain cancer	0.000326	0.0109	CbGeAlD
Rosuvastatin—ABCC4—central nervous system—brain cancer	0.000323	0.0108	CbGeAlD
Rosuvastatin—Hypersensitivity—Hydroxyurea—brain cancer	0.00032	0.00431	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Carmustine—brain cancer	0.00032	0.00431	CcSEcCtD
Rosuvastatin—Insomnia—Carmustine—brain cancer	0.000317	0.00428	CcSEcCtD
Rosuvastatin—SLCO1B1—Irinotecan Pathway—APC—brain cancer	0.000317	0.0124	CbGpPWpGaD
Rosuvastatin—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000316	0.0124	CbGpPWpGaD
Rosuvastatin—ABCG2—medulla oblongata—brain cancer	0.000315	0.0106	CbGeAlD
Rosuvastatin—Paraesthesia—Carmustine—brain cancer	0.000315	0.00425	CcSEcCtD
Rosuvastatin—Asthenia—Hydroxyurea—brain cancer	0.000311	0.0042	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000309	0.00416	CcSEcCtD
Rosuvastatin—Insomnia—Temozolomide—brain cancer	0.000307	0.00413	CcSEcCtD
Rosuvastatin—Paraesthesia—Temozolomide—brain cancer	0.000304	0.0041	CcSEcCtD
Rosuvastatin—Constipation—Carmustine—brain cancer	0.0003	0.00405	CcSEcCtD
Rosuvastatin—Pain—Carmustine—brain cancer	0.0003	0.00405	CcSEcCtD
Rosuvastatin—Dyspepsia—Temozolomide—brain cancer	0.000298	0.00402	CcSEcCtD
Rosuvastatin—CYP2C19—endocrine gland—brain cancer	0.000298	0.00999	CbGeAlD
Rosuvastatin—Diarrhoea—Hydroxyurea—brain cancer	0.000297	0.004	CcSEcCtD
Rosuvastatin—ABCG2—Irinotecan Pathway—APC—brain cancer	0.000293	0.0115	CbGpPWpGaD
Rosuvastatin—Cough—Etoposide—brain cancer	0.00029	0.00391	CcSEcCtD
Rosuvastatin—Constipation—Temozolomide—brain cancer	0.00029	0.00391	CcSEcCtD
Rosuvastatin—Pain—Temozolomide—brain cancer	0.00029	0.00391	CcSEcCtD
Rosuvastatin—SLCO2B1—brain—brain cancer	0.000289	0.0097	CbGeAlD
Rosuvastatin—Feeling abnormal—Carmustine—brain cancer	0.000289	0.0039	CcSEcCtD
Rosuvastatin—ABCG2—midbrain—brain cancer	0.000288	0.00965	CbGeAlD
Rosuvastatin—Dizziness—Hydroxyurea—brain cancer	0.000287	0.00387	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Carmustine—brain cancer	0.000287	0.00387	CcSEcCtD
Rosuvastatin—ABCG2—spinal cord—brain cancer	0.000281	0.00942	CbGeAlD
Rosuvastatin—Feeling abnormal—Temozolomide—brain cancer	0.000279	0.00377	CcSEcCtD
Rosuvastatin—Abdominal pain—Carmustine—brain cancer	0.000277	0.00374	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Temozolomide—brain cancer	0.000277	0.00374	CcSEcCtD
Rosuvastatin—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000277	0.0108	CbGpPWpGaD
Rosuvastatin—Rash—Hydroxyurea—brain cancer	0.000274	0.00369	CcSEcCtD
Rosuvastatin—Confusional state—Etoposide—brain cancer	0.000274	0.00369	CcSEcCtD
Rosuvastatin—Dermatitis—Hydroxyurea—brain cancer	0.000273	0.00369	CcSEcCtD
Rosuvastatin—Headache—Hydroxyurea—brain cancer	0.000272	0.00367	CcSEcCtD
Rosuvastatin—Infection—Etoposide—brain cancer	0.000269	0.00363	CcSEcCtD
Rosuvastatin—Urticaria—Temozolomide—brain cancer	0.000269	0.00363	CcSEcCtD
Rosuvastatin—ABCC1—cerebellum—brain cancer	0.000269	0.00902	CbGeAlD
Rosuvastatin—Abdominal pain—Temozolomide—brain cancer	0.000268	0.00361	CcSEcCtD
Rosuvastatin—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000266	0.0104	CbGpPWpGaD
Rosuvastatin—SLCO1A2—brain—brain cancer	0.000266	0.00893	CbGeAlD
Rosuvastatin—Thrombocytopenia—Etoposide—brain cancer	0.000266	0.00358	CcSEcCtD
Rosuvastatin—ALB—brain—brain cancer	0.000265	0.00888	CbGeAlD
Rosuvastatin—Hypersensitivity—Carmustine—brain cancer	0.000258	0.00349	CcSEcCtD
Rosuvastatin—Nausea—Hydroxyurea—brain cancer	0.000258	0.00348	CcSEcCtD
Rosuvastatin—ABCC4—brain—brain cancer	0.000256	0.00859	CbGeAlD
Rosuvastatin—Asthenia—Carmustine—brain cancer	0.000252	0.00339	CcSEcCtD
Rosuvastatin—Hypersensitivity—Temozolomide—brain cancer	0.00025	0.00337	CcSEcCtD
Rosuvastatin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000247	0.00967	CbGpPWpGaD
Rosuvastatin—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000244	0.00954	CbGpPWpGaD
Rosuvastatin—Paraesthesia—Etoposide—brain cancer	0.000244	0.00328	CcSEcCtD
Rosuvastatin—Asthenia—Temozolomide—brain cancer	0.000243	0.00328	CcSEcCtD
Rosuvastatin—HMGCR—SREBP signalling—SIRT1—brain cancer	0.000241	0.0094	CbGpPWpGaD
Rosuvastatin—Diarrhoea—Carmustine—brain cancer	0.00024	0.00324	CcSEcCtD
Rosuvastatin—Pruritus—Temozolomide—brain cancer	0.00024	0.00323	CcSEcCtD
Rosuvastatin—CYP3A5—endocrine gland—brain cancer	0.000235	0.00787	CbGeAlD
Rosuvastatin—Dizziness—Carmustine—brain cancer	0.000232	0.00313	CcSEcCtD
Rosuvastatin—Constipation—Etoposide—brain cancer	0.000232	0.00313	CcSEcCtD
Rosuvastatin—Pain—Etoposide—brain cancer	0.000232	0.00313	CcSEcCtD
Rosuvastatin—Diarrhoea—Temozolomide—brain cancer	0.000232	0.00313	CcSEcCtD
Rosuvastatin—CYP2C9—endocrine gland—brain cancer	0.000231	0.00775	CbGeAlD
Rosuvastatin—Dizziness—Temozolomide—brain cancer	0.000224	0.00302	CcSEcCtD
Rosuvastatin—Feeling abnormal—Etoposide—brain cancer	0.000224	0.00301	CcSEcCtD
Rosuvastatin—ABCG2—cerebellum—brain cancer	0.000223	0.00747	CbGeAlD
Rosuvastatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000222	0.00869	CbGpPWpGaD
Rosuvastatin—Gastrointestinal pain—Etoposide—brain cancer	0.000222	0.00299	CcSEcCtD
Rosuvastatin—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000221	0.00865	CbGpPWpGaD
Rosuvastatin—Rash—Carmustine—brain cancer	0.000221	0.00298	CcSEcCtD
Rosuvastatin—Dermatitis—Carmustine—brain cancer	0.000221	0.00298	CcSEcCtD
Rosuvastatin—Headache—Carmustine—brain cancer	0.00022	0.00296	CcSEcCtD
Rosuvastatin—ABCC1—brain—brain cancer	0.000219	0.00733	CbGeAlD
Rosuvastatin—SLC7A11—Hemostasis—MPL—brain cancer	0.000218	0.00852	CbGpPWpGaD
Rosuvastatin—Urticaria—Etoposide—brain cancer	0.000215	0.00291	CcSEcCtD
Rosuvastatin—Abdominal pain—Etoposide—brain cancer	0.000214	0.00289	CcSEcCtD
Rosuvastatin—Rash—Temozolomide—brain cancer	0.000214	0.00288	CcSEcCtD
Rosuvastatin—Dermatitis—Temozolomide—brain cancer	0.000214	0.00288	CcSEcCtD
Rosuvastatin—Headache—Temozolomide—brain cancer	0.000212	0.00286	CcSEcCtD
Rosuvastatin—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.00021	0.00821	CbGpPWpGaD
Rosuvastatin—SLC7A11—Hemostasis—S100A10—brain cancer	0.000209	0.00817	CbGpPWpGaD
Rosuvastatin—ABCC4—Platelet activation, signaling and aggregation—MPL—brain cancer	0.000209	0.00816	CbGpPWpGaD
Rosuvastatin—Nausea—Carmustine—brain cancer	0.000208	0.00281	CcSEcCtD
Rosuvastatin—ABCG2—HIF-2-alpha transcription factor network—SIRT1—brain cancer	0.000203	0.00792	CbGpPWpGaD
Rosuvastatin—Nausea—Temozolomide—brain cancer	0.000201	0.00272	CcSEcCtD
Rosuvastatin—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000201	0.00784	CbGpPWpGaD
Rosuvastatin—Hypersensitivity—Etoposide—brain cancer	0.0002	0.0027	CcSEcCtD
Rosuvastatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000198	0.00775	CbGpPWpGaD
Rosuvastatin—Asthenia—Etoposide—brain cancer	0.000195	0.00262	CcSEcCtD
Rosuvastatin—Pruritus—Etoposide—brain cancer	0.000192	0.00259	CcSEcCtD
Rosuvastatin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000191	0.00747	CbGpPWpGaD
Rosuvastatin—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00019	0.00743	CbGpPWpGaD
Rosuvastatin—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000189	0.00738	CbGpPWpGaD
Rosuvastatin—Diarrhoea—Etoposide—brain cancer	0.000186	0.0025	CcSEcCtD
Rosuvastatin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000181	0.00708	CbGpPWpGaD
Rosuvastatin—ABCG2—brain—brain cancer	0.000181	0.00607	CbGeAlD
Rosuvastatin—SLC7A11—Transmembrane transport of small molecules—S100A10—brain cancer	0.000181	0.00707	CbGpPWpGaD
Rosuvastatin—Dizziness—Etoposide—brain cancer	0.000179	0.00242	CcSEcCtD
Rosuvastatin—CYP3A4—endocrine gland—brain cancer	0.000176	0.00591	CbGeAlD
Rosuvastatin—HMGCR—AMPK Signaling—PIK3CG—brain cancer	0.000171	0.00669	CbGpPWpGaD
Rosuvastatin—Rash—Etoposide—brain cancer	0.000171	0.00231	CcSEcCtD
Rosuvastatin—Dermatitis—Etoposide—brain cancer	0.000171	0.0023	CcSEcCtD
Rosuvastatin—Headache—Etoposide—brain cancer	0.00017	0.00229	CcSEcCtD
Rosuvastatin—Nausea—Etoposide—brain cancer	0.000161	0.00217	CcSEcCtD
Rosuvastatin—CYP3A4—central nervous system—brain cancer	0.000159	0.00532	CbGeAlD
Rosuvastatin—ABCC1—S1P1 pathway—VEGFA—brain cancer	0.000156	0.0061	CbGpPWpGaD
Rosuvastatin—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000155	0.00606	CbGpPWpGaD
Rosuvastatin—SLC7A11—Hemostasis—BSG—brain cancer	0.000147	0.00575	CbGpPWpGaD
Rosuvastatin—ABCC4—Ectoderm Differentiation—SHH—brain cancer	0.00014	0.00546	CbGpPWpGaD
Rosuvastatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000139	0.00543	CbGpPWpGaD
Rosuvastatin—SLCO2B1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000135	0.00527	CbGpPWpGaD
Rosuvastatin—HMGCR—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000131	0.00512	CbGpPWpGaD
Rosuvastatin—HMGCR—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.000129	0.00503	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000119	0.00467	CbGpPWpGaD
Rosuvastatin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000115	0.00449	CbGpPWpGaD
Rosuvastatin—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000114	0.00444	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—MPL—brain cancer	0.000108	0.00421	CbGpPWpGaD
Rosuvastatin—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.000107	0.00416	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Transmembrane transport of small molecules—S100A10—brain cancer	0.000105	0.00412	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.000105	0.00411	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—S100A10—brain cancer	0.000103	0.00403	CbGpPWpGaD
Rosuvastatin—CYP3A4—Irinotecan Pathway—APC—brain cancer	9.77e-05	0.00382	CbGpPWpGaD
Rosuvastatin—HMGCR—Integrated Breast Cancer Pathway—CDK4—brain cancer	9.73e-05	0.0038	CbGpPWpGaD
Rosuvastatin—SLC7A11—Hemostasis—TRPC6—brain cancer	9.65e-05	0.00377	CbGpPWpGaD
Rosuvastatin—ALB—Platelet activation, signaling and aggregation—MPL—brain cancer	9.45e-05	0.00369	CbGpPWpGaD
Rosuvastatin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	9.32e-05	0.00364	CbGpPWpGaD
Rosuvastatin—ABCC4—Platelet activation, signaling and aggregation—TRPC6—brain cancer	9.25e-05	0.00361	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	9.18e-05	0.00359	CbGpPWpGaD
Rosuvastatin—ABCC4—Fluoropyrimidine Activity—TP53—brain cancer	9.1e-05	0.00356	CbGpPWpGaD
Rosuvastatin—ABCC4—Transmembrane transport of small molecules—S100A10—brain cancer	8.93e-05	0.00349	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism of lipids and lipoproteins—IDH1—brain cancer	8.74e-05	0.00341	CbGpPWpGaD
Rosuvastatin—ALB—Vitamin B12 Metabolism—SOD2—brain cancer	8.7e-05	0.0034	CbGpPWpGaD
Rosuvastatin—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	8.66e-05	0.00339	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	8.64e-05	0.00338	CbGpPWpGaD
Rosuvastatin—ABCG2—HIF-2-alpha transcription factor network—VEGFA—brain cancer	8.62e-05	0.00337	CbGpPWpGaD
Rosuvastatin—SLC7A11—Transmembrane transport of small molecules—TRPC6—brain cancer	8.35e-05	0.00326	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Transmembrane transport of small molecules—S100A10—brain cancer	8.27e-05	0.00323	CbGpPWpGaD
Rosuvastatin—CYP2C19—Biological oxidations—CYP2C9—brain cancer	8.24e-05	0.00322	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	8.12e-05	0.00317	CbGpPWpGaD
Rosuvastatin—HMGCR—AMPK Signaling—TP53—brain cancer	7.74e-05	0.00303	CbGpPWpGaD
Rosuvastatin—ABCC1—Transmembrane transport of small molecules—S100A10—brain cancer	7.45e-05	0.00291	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—BSG—brain cancer	7.27e-05	0.00284	CbGpPWpGaD
Rosuvastatin—SLC7A11—Hemostasis—VAV1—brain cancer	7.23e-05	0.00283	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.21e-05	0.00282	CbGpPWpGaD
Rosuvastatin—ALB—Folate Metabolism—SOD2—brain cancer	7.08e-05	0.00277	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Transmembrane transport of small molecules—S100A10—brain cancer	7.08e-05	0.00277	CbGpPWpGaD
Rosuvastatin—ABCC4—Platelet activation, signaling and aggregation—VAV1—brain cancer	6.93e-05	0.00271	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—IDH1—brain cancer	6.71e-05	0.00262	CbGpPWpGaD
Rosuvastatin—ABCG2—Fluoropyrimidine Activity—TP53—brain cancer	6.67e-05	0.00261	CbGpPWpGaD
Rosuvastatin—ABCG2—Transmembrane transport of small molecules—S100A10—brain cancer	6.55e-05	0.00256	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	6.49e-05	0.00254	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism of lipids and lipoproteins—IDH1—brain cancer	6.32e-05	0.00247	CbGpPWpGaD
Rosuvastatin—HMGCR—Integrated Breast Cancer Pathway—CCND1—brain cancer	6.28e-05	0.00245	CbGpPWpGaD
Rosuvastatin—SLCO2B1—Transmembrane transport of small molecules—TRPC6—brain cancer	6.23e-05	0.00243	CbGpPWpGaD
Rosuvastatin—HMGCR—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	6.22e-05	0.00243	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	6.17e-05	0.00241	CbGpPWpGaD
Rosuvastatin—ABCC4—Platelet degranulation—VEGFA—brain cancer	5.93e-05	0.00232	CbGpPWpGaD
Rosuvastatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	5.92e-05	0.00232	CbGpPWpGaD
Rosuvastatin—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	5.65e-05	0.00221	CbGpPWpGaD
Rosuvastatin—ALB—Selenium Micronutrient Network—SOD2—brain cancer	5.62e-05	0.0022	CbGpPWpGaD
Rosuvastatin—HMGCR—Integrated Breast Cancer Pathway—VEGFA—brain cancer	5.47e-05	0.00214	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—CYP2C9—brain cancer	5.32e-05	0.00208	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.27e-05	0.00206	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—DTX2—brain cancer	5.11e-05	0.002	CbGpPWpGaD
Rosuvastatin—ABCG2—HIF-1-alpha transcription factor network—VEGFA—brain cancer	5.07e-05	0.00198	CbGpPWpGaD
Rosuvastatin—HMGCR—Integrated Breast Cancer Pathway—MYC—brain cancer	5.04e-05	0.00197	CbGpPWpGaD
Rosuvastatin—ALB—Vitamin B12 Metabolism—RELA—brain cancer	5.03e-05	0.00196	CbGpPWpGaD
Rosuvastatin—CYP3A4—Biological oxidations—CYP2C9—brain cancer	4.95e-05	0.00194	CbGpPWpGaD
Rosuvastatin—HMGCR—Integrated Breast Cancer Pathway—EGFR—brain cancer	4.93e-05	0.00193	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	4.88e-05	0.00191	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—MPL—brain cancer	4.87e-05	0.0019	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Transmembrane transport of small molecules—TRPC6—brain cancer	4.86e-05	0.0019	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—TRPC6—brain cancer	4.77e-05	0.00186	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.74e-05	0.00185	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—S100A10—brain cancer	4.67e-05	0.00183	CbGpPWpGaD
Rosuvastatin—SLC7A11—Hemostasis—PIK3CG—brain cancer	4.59e-05	0.00179	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—BSG—brain cancer	4.52e-05	0.00177	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.51e-05	0.00176	CbGpPWpGaD
Rosuvastatin—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	4.4e-05	0.00172	CbGpPWpGaD
Rosuvastatin—ABCC4—Ectoderm Differentiation—CTNNB1—brain cancer	4.36e-05	0.0017	CbGpPWpGaD
Rosuvastatin—ALB—Platelet activation, signaling and aggregation—TRPC6—brain cancer	4.18e-05	0.00164	CbGpPWpGaD
Rosuvastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—brain cancer	4.14e-05	0.00162	CbGpPWpGaD
Rosuvastatin—ABCC4—Transmembrane transport of small molecules—TRPC6—brain cancer	4.13e-05	0.00161	CbGpPWpGaD
Rosuvastatin—ALB—Folate Metabolism—RELA—brain cancer	4.09e-05	0.0016	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—CYP2C9—brain cancer	4.09e-05	0.0016	CbGpPWpGaD
Rosuvastatin—ALB—Transmembrane transport of small molecules—S100A10—brain cancer	4.04e-05	0.00158	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—IDH1—brain cancer	3.89e-05	0.00152	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—CYP2C9—brain cancer	3.85e-05	0.0015	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Transmembrane transport of small molecules—TRPC6—brain cancer	3.82e-05	0.00149	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—HES5—brain cancer	3.75e-05	0.00147	CbGpPWpGaD
Rosuvastatin—ALB—Folate Metabolism—IL2—brain cancer	3.68e-05	0.00144	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—VAV1—brain cancer	3.57e-05	0.0014	CbGpPWpGaD
Rosuvastatin—ABCC4—Ectoderm Differentiation—MYC—brain cancer	3.53e-05	0.00138	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.52e-05	0.00138	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—BSG—brain cancer	3.48e-05	0.00136	CbGpPWpGaD
Rosuvastatin—ABCC1—Transmembrane transport of small molecules—TRPC6—brain cancer	3.44e-05	0.00134	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—BSG—brain cancer	3.29e-05	0.00129	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—BSG—brain cancer	3.27e-05	0.00128	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Transmembrane transport of small molecules—TRPC6—brain cancer	3.27e-05	0.00128	CbGpPWpGaD
Rosuvastatin—ALB—Selenium Micronutrient Network—RELA—brain cancer	3.25e-05	0.00127	CbGpPWpGaD
Rosuvastatin—SLC7A11—Hemostasis—IL2—brain cancer	3.23e-05	0.00126	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—CYP2C9—brain cancer	3.21e-05	0.00126	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.17e-05	0.00124	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.16e-05	0.00124	CbGpPWpGaD
Rosuvastatin—ALB—Platelet activation, signaling and aggregation—VAV1—brain cancer	3.13e-05	0.00123	CbGpPWpGaD
Rosuvastatin—ABCC4—Platelet activation, signaling and aggregation—IL2—brain cancer	3.1e-05	0.00121	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—ENO2—brain cancer	3.08e-05	0.0012	CbGpPWpGaD
Rosuvastatin—ABCG2—Transmembrane transport of small molecules—TRPC6—brain cancer	3.03e-05	0.00118	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—IDH1—brain cancer	2.99e-05	0.00117	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—CYP2C9—brain cancer	2.89e-05	0.00113	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—IDH1—brain cancer	2.81e-05	0.0011	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—CYP2C9—brain cancer	2.75e-05	0.00107	CbGpPWpGaD
Rosuvastatin—SLC7A11—Hemostasis—VEGFA—brain cancer	2.75e-05	0.00107	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—BSG—brain cancer	2.73e-05	0.00107	CbGpPWpGaD
Rosuvastatin—ALB—Platelet degranulation—VEGFA—brain cancer	2.68e-05	0.00105	CbGpPWpGaD
Rosuvastatin—ABCC4—Platelet activation, signaling and aggregation—VEGFA—brain cancer	2.63e-05	0.00103	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.58e-05	0.00101	CbGpPWpGaD
Rosuvastatin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	2.56e-05	0.000999	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—CYP2C9—brain cancer	2.54e-05	0.000994	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—IDH1—brain cancer	2.52e-05	0.000986	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—BSG—brain cancer	2.46e-05	0.00096	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.43e-05	0.000951	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—HEY1—brain cancer	2.39e-05	0.000935	CbGpPWpGaD
Rosuvastatin—ALB—Folate Metabolism—TP53—brain cancer	2.37e-05	0.000924	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—ENO2—brain cancer	2.36e-05	0.000923	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—IDH1—brain cancer	2.35e-05	0.000918	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—DLL1—brain cancer	2.35e-05	0.000917	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—BSG—brain cancer	2.33e-05	0.000913	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.31e-05	0.000904	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.29e-05	0.000895	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—PIK3CG—brain cancer	2.27e-05	0.000886	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—ENO2—brain cancer	2.22e-05	0.000869	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—BSG—brain cancer	2.16e-05	0.000845	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—TRPC6—brain cancer	2.16e-05	0.000843	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—IDH1—brain cancer	2.11e-05	0.000826	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.11e-05	0.000824	CbGpPWpGaD
Rosuvastatin—SLC7A11—Hemostasis—TP53—brain cancer	2.07e-05	0.000811	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—IDH1—brain cancer	2.01e-05	0.000785	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—SHH—brain cancer	1.99e-05	0.000779	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—ENO2—brain cancer	1.99e-05	0.000779	CbGpPWpGaD
Rosuvastatin—ALB—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	1.99e-05	0.000778	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.91e-05	0.000747	CbGpPWpGaD
Rosuvastatin—ALB—Transmembrane transport of small molecules—TRPC6—brain cancer	1.87e-05	0.00073	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—IDH1—brain cancer	1.86e-05	0.000727	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—ENO2—brain cancer	1.86e-05	0.000725	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—CYP2C9—brain cancer	1.82e-05	0.000712	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.72e-05	0.000672	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—ENO2—brain cancer	1.67e-05	0.000653	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.63e-05	0.000639	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—VAV1—brain cancer	1.62e-05	0.000632	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—IL2—brain cancer	1.6e-05	0.000624	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—ENO2—brain cancer	1.59e-05	0.00062	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—CYP2C9—brain cancer	1.57e-05	0.000613	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—BSG—brain cancer	1.55e-05	0.000605	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—ENO2—brain cancer	1.47e-05	0.000574	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—VAV1—brain cancer	1.44e-05	0.000563	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—PIK3CG—brain cancer	1.41e-05	0.000551	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—CYP2C9—brain cancer	1.41e-05	0.00055	CbGpPWpGaD
Rosuvastatin—ALB—Platelet activation, signaling and aggregation—IL2—brain cancer	1.4e-05	0.000547	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—VEGFA—brain cancer	1.36e-05	0.00053	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—BSG—brain cancer	1.33e-05	0.000521	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—IDH1—brain cancer	1.33e-05	0.000521	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—HES1—brain cancer	1.24e-05	0.000484	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—BSG—brain cancer	1.2e-05	0.000468	CbGpPWpGaD
Rosuvastatin—ALB—Platelet activation, signaling and aggregation—VEGFA—brain cancer	1.19e-05	0.000465	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—PDGFRA—brain cancer	1.18e-05	0.000461	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—IDH1—brain cancer	1.15e-05	0.000448	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—BSG—brain cancer	1.09e-05	0.000427	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—PIK3CG—brain cancer	1.08e-05	0.000424	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—ENO2—brain cancer	1.05e-05	0.000412	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—IRS2—brain cancer	1.04e-05	0.000405	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—IDH1—brain cancer	1.03e-05	0.000402	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—PIK3CG—brain cancer	1.03e-05	0.000401	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—TP53—brain cancer	1.02e-05	0.0004	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—PIK3CG—brain cancer	1.02e-05	0.000399	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—IDH1—brain cancer	9.39e-06	0.000367	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.34e-06	0.000365	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—APC—brain cancer	9.15e-06	0.000358	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—ENO2—brain cancer	9.07e-06	0.000354	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—PIK3CG—brain cancer	8.51e-06	0.000333	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—CYP2C9—brain cancer	8.47e-06	0.000331	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.39e-06	0.000328	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—ENO2—brain cancer	8.14e-06	0.000318	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—PIK3CG—brain cancer	7.66e-06	0.000299	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.65e-06	0.000299	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—ENO2—brain cancer	7.42e-06	0.00029	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—PIK3CG—brain cancer	7.28e-06	0.000285	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—IL2—brain cancer	7.22e-06	0.000282	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—BSG—brain cancer	7.2e-06	0.000281	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—ERBB2—brain cancer	7.1e-06	0.000278	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—PIK3CG—brain cancer	6.74e-06	0.000263	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—CTNNB1—brain cancer	6.22e-06	0.000243	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—IDH1—brain cancer	6.19e-06	0.000242	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—VEGFA—brain cancer	6.14e-06	0.00024	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—STAT3—brain cancer	5.42e-06	0.000212	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—MYC—brain cancer	5.03e-06	0.000197	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—EGFR—brain cancer	4.92e-06	0.000192	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—ENO2—brain cancer	4.9e-06	0.000191	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PIK3CG—brain cancer	4.83e-06	0.000189	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—TP53—brain cancer	4.64e-06	0.000181	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PIK3CG—brain cancer	4.16e-06	0.000163	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PIK3CG—brain cancer	3.73e-06	0.000146	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PIK3CG—brain cancer	3.41e-06	0.000133	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PIK3CG—brain cancer	2.25e-06	8.78e-05	CbGpPWpGaD
